Featured Story

$19M in FDA grants will support rare disease research

The FDA has awarded 15 grants totaling more than $19 million to spur the development of medical devices and drugs to help treat rare diseases.

Gates Foundation funds monkey study of new HIV vaccine

Swiss firm Mymetics is getting a boost from the Bill and Melinda Gates Foundation to conduct a key animal study for its HIV vaccine candidate at the Texas Biomedical Research Institute.

Protein 'map' points way to combating chemo-resistant cancer

In an effort to better understand a certain disease-causing enzyme, British researchers have created a "map" of more than 100 proteins this enzyme is known to affect. They then identified a druglike molecule that blocks this enzyme to preserve these essential proteins.

New class of antibiotics could fight drug-resistant tuberculosis

Scientists have figured out how an emerging class of antibiotics binds to the bacterium that causes tuberculosis--a discovery that could lead to new therapeutics to fight the disease, which is becoming resistant to commonly used antimicrobials in many parts of the world.

Hemispherx to test FDA-rejected drug, other candidates against Ebola

As the ongoing Ebola outbreak in West Africa worsens, small and large companies alike are touting their investigational drugs in response to the World Health Organization's appeal to speed up research and development in the field.


From Our Sister Sites


Roche's Genentech unit is getting some high-profile blowback from a change to its distribution model on three top cancer meds. Hospital and pharmacy executives claim the new regime--which restricts Avastin, Rituxan and Herceptin to a half-dozen specialty distributors--will cost them big money.


Boehringer Ingelheim envisions some day selling day a smart inhaler that can tell patients when its medication is running low and remind them if they missed a prescheduled dose.